Sumitomo Pharma Co. Ltd.

In News

Takeda Pharmaceutical Company Limited (4502.T) stock price, news, quote and history - Yahoo Finance UK

Yahoo Finance UK - Oct 17, 2026

Sumitomo Pharma America Announces First Patient Receives Treatment in Phase 1/2a Study for its Investigational Therapy DSP-3077 for Retinitis Pigmentosa - BioSpace

BioSpace - Aug 12, 2026

Press Release Service: Sumitomo Pharma America Announces Enzomenib (DSP-5336) Receives FDA Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia - CRISPR Medicine News

CRISPR Medicine News - Aug 03, 2026

Sumitomo Pharma America Earns 2026-2027 Great Place to Work Certification™ - Business Wire

Business Wire - Aug 06, 2026

Sumitomo Pharma Co Ltd - Regarding A Report Concerning Sumitomo Pharma ( Company's Views On Gcr August 7 Report) - TradingView

TradingView - Aug 11, 2026

Sumitomo Pharma America Announces that its Investigational Therapy DSP-3077 Has Received FDA Orphan Drug Designation for the Treatment of Retinitis Pigmentosa - PR Newswire

PR Newswire - Mar 23, 2026

Short seller Gotham City Research accuses Sumitomo Pharma of misstating revenue - Investing.com

Investing.com - Aug 03, 2026

Sumitomo Pharma's (TSE:4506) Attractive Earnings Are Not All Good News For Shareholders - Simply Wall Street

Simply Wall Street - Aug 09, 2026

Sumitomo Pharma Shares Drop After Stem-Therapy Backing - Bloomberg.com

Bloomberg.com - Feb 19, 2026

Cytonome Congratulates Sumitomo Pharma on Regulatory Approval for Regenerative Medicine Therapy for Parkinson’s disease - BioInformant

BioInformant - Mar 11, 2026

Sumitomo Pharma America Achieves Key Patient Enrollment Milestone for Pivotal Phase 2 Study of Enzomenib in the Treatment of Relapsed/Refractory Acute Leukemia - Business Wire

Business Wire - Jun 10, 2026

EBIT per share of Sumitomo Pharma Co.Ltd. – HAN:DPM - TradingView

TradingView - Sep 29, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment